News

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...
Novo Nordisk A/S (NYSE:NVO) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company discontinued ...
Novo Nordisk is expanding access to its drug Wegovy through a new partnership with WeightWatchers, days after cutting ties with telehealth firm Hims & Hers. Starting July 1, WeightWatchers will ...
Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 10 Stocks Delivering Eye-Popping Gains. Hims & Hers rebounded by 11.76 ...
A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...
The talk show host - who once topped the scales at 237lbs in 1992 - finally reached her 160lb goal weight in 2023 after ...
Jenny Mollen opened up about how microdosing GLP1 medication ended up sending her to the emergency room. "I just posted a follow-up to my piece about Tirzepatide and microdosing," Mollen, 46, said in ...
Meta Platforms, Inc. (NASDAQ:META) is one of the 13 Best Long Term Growth Stocks to Invest in Right Now. On June 24, DBS analyst Sachin Mittal maintained a Buy rating on Meta Platforms, Inc.
The Mounjaro weight-loss jab is now available from GPs the NHS, but only for a limited group of patients with a BMI over 35 ...